| 226 |
Nanosized Combined Antimicrobial Drugs Decreased Emergence of Resistance in Escherichia coli: A Future Promise |
Department of Microbiology and Immunology |
2022 |
| 227 |
Drug therapy in patients with severe forms of sickle cell anemia: A nonrandomized clinical trial of combining l-carnitine with hydroxycarbamide therapy |
Internal Medicine |
2022 |
| 228 |
Intrapatient variability of 18F-FDG uptake in normal tissues |
Department of Clinical Oncology and Nuclear Medicine |
2022 |
| 229 |
Donohue syndrome in an Egyptian infant: a case report |
Department of Pediatrics |
2022 |
| 230 |
Elevated hippocampal mGlut2 receptors in rats with metabolic syndrome-induced-memory impairment, possible protection by vitamin D. |
Department of Medical Physiology |
2022 |
| 231 |
Single-bone versus both-bone plating of unstable paediatric both-bone forearm fractures. A randomized controlled clinical trial |
Department of Orthopedic Surgery and Traumatology |
2022 |
| 232 |
Severity scoring systems and different biochemical markers as predictors of mortality in the respiratory ICU |
Department of Chest Diseases |
2022 |
| 233 |
A Novel C Fe Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma |
Department of Microbiology and Immunology |
2022 |
| 234 |
Predictors of Subclinical Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease Patients |
Internal Medicine |
2022 |
